Listen
SUXAMETHONIUM PANPHARMA (suxamethonium chloride)
Reason for request
-
Clinical Benefit
| Substantial |
The Committee issues a favourable opinion for inclusion in the hospital formulary list of reimbursed proprietary medicinal products approved for use only as an adjuvant to general anaesthesia to facilitate tracheal intubation in rapid sequence induction, justified by a risk of inhalation of gastric contents. |
| Insufficient |
The Committee issues an unfavourable opinion for inclusion in the hospital formulary list of reimbursed proprietary medicinal products approved for use in the other clinical situations of the MA, in particular for short-term muscle relaxation during general anaesthesia and for use as infusion. |
Clinical Added Value
| no clinical added value |
This medicinal product is a euro-generic that provides no clinical added value (CAV V) compared to the other medicinal products for injection available containing suxamethonium chloride. |
